Reply to: "Parkinson's Disease and COVID-19: Do We Need to Be More Patient?"

Mov Disord. 2021 Feb;36(2):278-279. doi: 10.1002/mds.28482.

Authors

Tiago F Outeiro^{1

2

3}, Anita Krisko¹

Affiliations

¹ Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, University Medical Center Goettingen, Goettingen, Germany.
² Max Planck Institute for Experimental Medicine, Goettingen, Germany.
³ Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, Upon Tyne, United Kingdom.

No abstract available

Keywords: COVID-19; Parkinson's disease; aging; SARS-CoV-2; neurodegenerative disease.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Aging
COVID-19*
Humans
Parkinson Disease*
SARS-CoV-2

Grants and funding

MBExC/Deutsche Forschungsgemeinschaft